Young Male Adults Have Lower Cancer Burden Than Women
Incidence of all invasive cancers decreased among men aged 20 to 49 years, increased in women
ASCO: Olaparib Beats Placebo for BRCA-Related Pancreatic Cancer
Progression-free survival significantly improved with olaparib versus placebo for metastatic disease
May 2019 Briefing – Gastroenterology
Here are what the editors at HealthDay consider to be the most important developments in Gastroenterology for May 2019. This roundup includes the latest...
ASCO: Low-Dose Chemo Benefits Advanced Gastroesophageal Cancer
Elderly, frail receiving 60 percent of oxaliplatin/capecitabine dose have noninferior PFS, less toxicity
ASCO: Pembrolizumab Noninferior to Chemo in Advanced Gastric Cancer
For patients with PD-L1 combined positive score of ≥10, pembrolizumab prolongs overall survival
ACP Issues Position on Response to Physician Impairment
Rehabilitated doctors should be reintegrated into practice as long as patient safety not compromised
Lupus Manifestations Appear to Differ by Race, Ethnicity
Increased risk for severe manifestations seen among blacks, Hispanics, and Asians/Pacific Islanders
Excess Cause-Specific Mortality Tied to Chronic Proton Pump Inhibitor Use
Excess mortality due to CVD, CKD, upper GI cancer for those with no indication for PPI use
High Costs Associated With Physician Burnout in U.S.
Nationally, about $4.6 billion in costs are related to physician turnover, reduced clinical hours
Early-Onset CRC Rising Fastest for Whites in Western States
Neither increases in prevalence of obesity nor heavy alcohol consumption correlated with CRC trends
